Schwab Health Care holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Schwab Health Care Fund™ SWHFX
- NAV / 1-Day Return 25.25 / −0.20 %
- Total Assets 625.4M
-
Adj. Expense Ratio
0.800%
- Expense Ratio 0.800%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Health
- Investment Style Large Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.97%
- Turnover 41%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:38 AM GMT+0
Morningstar’s Analysis SWHFX
Will SWHFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the SWHFX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of SWHFX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 11.52 | 73M | Healthcare |
Johnson & Johnson | 7.69 | 48M | Healthcare |
AbbVie Inc | 5.89 | 37M | Healthcare |
Merck & Co Inc | 4.94 | 31M | Healthcare |
Gilead Sciences Inc | 4.29 | 27M | Healthcare |
Stryker Corp | 3.11 | 20M | Healthcare |
Novartis AG Registered Shares | 3.03 | 19M | Healthcare |
Medtronic PLC | 3.02 | 19M | Healthcare |
AstraZeneca PLC | 2.71 | 17M | Healthcare |
Amgen Inc | 2.70 | 17M | Healthcare |
United States